Wells Fargo & Company Grifols Sa Transaction History

Wells Fargo & Company

  • $429 Billion
  • Q1 2025

A detailed history of Wells Fargo & Company transactions in Grifols Sa stock. As of the latest transaction made, Wells Fargo & Company holds 768,311 shares of GRFS stock, worth $8.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
768,311
Previous 625,453 22.84%
Holding current value
$8.14 Million
Previous $4.65 Million 17.39%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
BUY
$6.62 - $8.71 $945,719 - $1.24 Million
142,858 Added 22.84%
768,311 $5.46 Million
Q4 2024

Feb 12, 2025
SELL
$6.99 - $9.55 $472,146 - $645,064
-67,546 Reduced 9.75%
625,453 $4.65 Million
Q3 2024

Nov 13, 2024
SELL
$6.28 - $9.38 $219,278 - $327,521
-34,917 Reduced 4.8%
692,999 $6.15 Million
Q2 2024

Aug 13, 2024
BUY
$6.27 - $7.7 $1.17 Million - $1.43 Million
186,099 Added 34.35%
727,916 $4.59 Million
Q1 2024

May 10, 2024
BUY
$5.47 - $11.38 $138,795 - $288,756
25,374 Added 4.91%
541,817 $3.62 Million
Q4 2023

Feb 09, 2024
BUY
$7.71 - $11.56 $407,820 - $611,466
52,895 Added 11.41%
516,443 $5.97 Million
Q3 2023

Nov 13, 2023
SELL
$8.91 - $10.91 $67,787 - $83,003
-7,608 Reduced 1.61%
463,548 $4.24 Million
Q2 2023

Aug 15, 2023
BUY
$7.14 - $9.29 $25,225 - $32,821
3,533 Added 0.76%
471,156 $4.32 Million
Q1 2023

May 12, 2023
BUY
$6.65 - $10.69 $399,006 - $641,410
60,001 Added 14.72%
467,623 $3.45 Million
Q4 2022

Feb 13, 2023
SELL
$5.96 - $8.53 $283,582 - $405,865
-47,581 Reduced 10.45%
407,622 $3.46 Million
Q3 2022

Nov 14, 2022
SELL
$5.95 - $14.3 $70,781 - $170,112
-11,896 Reduced 2.55%
455,203 $2.8 Million
Q2 2022

Aug 12, 2022
BUY
$10.6 - $13.28 $145,538 - $182,334
13,730 Added 3.03%
467,099 $5.55 Million
Q1 2022

May 16, 2022
BUY
$10.37 - $12.73 $1.33 Million - $1.63 Million
128,005 Added 39.34%
453,369 $5.3 Million
Q4 2021

Feb 14, 2022
BUY
$10.21 - $15.27 $7,208 - $10,780
706 Added 0.22%
325,364 $3.65 Million
Q3 2021

Nov 15, 2021
SELL
$14.07 - $17.3 $453,954 - $558,167
-32,264 Reduced 9.04%
324,658 $4.74 Million
Q2 2021

Aug 16, 2021
BUY
$16.62 - $18.94 $477,575 - $544,240
28,735 Added 8.76%
356,922 $6.19 Million
Q1 2021

May 13, 2021
BUY
$15.15 - $19.78 $717,125 - $936,286
47,335 Added 16.85%
328,187 $5.67 Million
Q4 2020

Feb 09, 2021
BUY
$16.86 - $19.67 $1.45 Million - $1.69 Million
85,827 Added 44.01%
280,852 $5.18 Million
Q3 2020

Nov 05, 2020
SELL
$15.4 - $20.16 $172,110 - $225,308
-11,176 Reduced 5.42%
195,025 $3.38 Million
Q2 2020

Aug 13, 2020
BUY
$18.24 - $21.45 $220,995 - $259,888
12,116 Added 6.24%
206,201 $3.76 Million
Q1 2020

May 14, 2020
BUY
$16.28 - $25.63 $3.16 Million - $4.97 Million
194,085 New
194,085 $3.91 Million

Others Institutions Holding GRFS

# of Institutions
167
Shares Held
153M
Call Options Held
76.5K
Put Options Held
106K
View Full List

About Grifols SA

GRFS Quotes by TradingView
  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $7.2B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email